Knowledge, Attitudes, and Practices Towards Pharmacovigilance Amongst Healthcare Providers at Edward Francis Small Teaching Hospital in the Gambia

Authors

  • Precious Ejiohuo American International University West Africa, Kanifing Industrial layout, Banjul and PO Box 3505, The Gambia

Keywords:

Pharmacovigilance (PV), Adverse Drug Reactions (ADR)

Abstract

Background: According to the World Health Organization, pharmacovigilance is the research and practices involved in the identification, evaluation, comprehension, and mitigation of side effects or any other hazard relating to medications or immunizations. Adverse Drug Reactions (ADRs) are a major public health concern in today`s world. As a result, ADR reporting in The Gambia must be taken seriously because drug-drug interactions, drug-disease interactions, or food-drug interactions can exacerbate ADRs that occur in the patient without the Healthcare providers' knowledge. More importantly, this research should support the need for legislation to prevent ADRs. This research was aimed to assess healthcare professionals' understanding, attitudes, and pharmacovigilance practices at The Gambia's Edward Francis Smalls Teaching Hospital. Methods: Healthcare providers from the Edward Francis Smalls Teaching Hospital in The Gambia participated in an observational, descriptive, and cross-sectional, questionnaire-based study to understand the extent of their knowledge, attitudes, and practices towards PV. The independent variables in the study were the socio-demographic factors used to characterize healthcare providers from the EFSTH. The sample size was calculated using software Epi info version7.Inclusion criteria was certified or licensed health care provider but those who are not willing to participate will not be included in the study. The data analysis was performed using Epi info version7. 2, Microsoft excel, MAXQDA and SPSS version 20. All statistical tests conducted were considered significant at 95% confidence interval with a p-value less than 0.05. Results: The response rate based on this sample size was 51% (n=102).

 A total of 102 participants were included in the final analysis, of which by profession the majority were Nurses 66 (64. 2%) and by gender most were female 58(56. 9%). Majority of the participants belong to the age of ranging from 20-37 years 89(87.5%).102(100%) of the respondents all agreed reporting ADR was necessary. Majority of the respondents 86(84.7%) had moderate knowledge score but however within the professions the pharmacist had a high score of 3(60%) amongst the participants. Most subjects 86(84.3%) had a positive level of attitude amongst the profession the nurses scored highest 57(86.4%). Most of the participants 81(79.4%) scored inadequate towards practices. By profession, Nurses had the most inadequate practices 55(53.9%), Doctors 22(21.6%), Pharmacist 3(2.9%) and physiotherapist 1(1%). In general, the practice towards pharmacovigilance was inadequate amongst most of the participants at the tertiary care Centre. The study found out a statistical significance between profession and Adverse Drug Reactions reporting training at p=0. 009. Conclusion: The study found out a statistical significance between profession and Adverse Drug Reactions reporting training at p=0. 009 which expose that most of the participants have not undergone training in area of pharmacovigilance and ADR Reporting alarming a need to include pharmacovigilance in undergraduate curriculum for healthcare providers. However, these findings are not surprising given the sample population in this study from low- and Middle-Income Countries (LMICs) like The Gambia is much more deprived of adequate education about Adverse Drug Reactions and pharmacovigilance activities compared to the general population in the developed nations. Therefore, there is a need for a national KAP study regarding the use of National Pharmacovigilance guidelines to be conducted in order to identify the key factors spurring low Adverse Drug reaction reporting rates within The Gambia.

References

Who.int. [Online]. Available: https://www.who.int/publications/i/item/10665-42493. [Accessed: 27-Oct-2022].

A. R. Abubakar, N. B. Simbak, and M. Haque, “A systematic review of knowledge, attitude and practice on adverse drug reactions and pharmacovigilance among doctors,” J. Appl. Pharm. Sci., vol. 4, no. 10, pp. 117–127, 2014.

R. Gupta, D. Sharma, and P. Malhotra, “assessment of knowledge, attitude and practice of pharmacovigilance among the undergraduate medical students in a Northern Indian tertiary care teaching hospital-an observational study,” international journal of pharmaceutical sciences and research, vol. 8, pp. 2654–2659, 2017.

A. S. Bhagavathula, A. A. Elnour, S. Q. Jamshed, and A. Shehab, “Health professionals’ knowledge, attitudes and practices about Pharmacovigilance in India: A systematic review and meta-analysis,” PLoS One, vol. 11, no. 3, p. e0152221, 2016.

Mca.gm. [Online]. Available: https://www.mca.gm. [Accessed: 28-Oct-2022].

R. D. Mann and E. B. Andrews, Pharmacovigilance, 2nd ed. Wiley, 2007.

B. Hugman, “The Erice declaration: the critical role of communication in drug safety,” Drug Saf., vol. 29, no. 1, pp. 91–93, 2006.

S. Sunwoo et al., “Post-marketing surveillance study of the safety and efficacy of sildenafil prescribed in primary care to erectile dysfunction patients,” Int. J. Impot. Res., vol. 17, no. 1, pp. 71–75, 2005.

N. Moore, “The role of the clinical pharmacologist in the management of adverse drug reactions,” Drug Saf., vol. 24, no. 1, pp. 1–7, 2001.

A. Singh, K. Twomey, and R. Baker, “Global pharmacovigilance regulations: Call for re-harmonization,” Clin. Trials, vol. 15, no. 6, pp. 631–632, 2018.

M. D. Rawlins, “Clinical pharmacology. Adverse reactions to drugs,” BMJ, vol. 282, no. 6268, pp. 974–976, 1981.

. J. Feely, S. Moriarty, and P. O’Connor, “Stimulating reporting of adverse drug reactions by using a fee,” BMJ, vol. 300, no. 6716, pp. 22–23, 1990.

. “2. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/ -

GoogleSearch,” Google.com[Online].Available:https://www.google.com/search?client=opera&q=2.%09http%3A%2F%2Fwww.who.int%2Fmedicines%2Fareas%2Fquality_safety%2Fsafety_+efficacy%2Fpharmvigi%2Fen%2F&sourceid=opera&ie=UTF-8&oe=UTF-8. [Accessed: 28-Oct-2022]

. Gupta SK. Pharmacovigilance: Current status and future challenges. Indian Journal of Medical Specialties. 2013 Jun;4(1):1-4.

. V. Srinivasan, D. Sheela, and D. Mridula, “Knowledge, attitude and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital-A questionnaire study,” Biomedical & Pharmacology Journal, vol. 10, no. 3, pp. 1441–1447, 2017.

T. Salehi, N. Seyedfatemi, M. S. Mirzaee, M. Maleki, and A. Mardani, “Nurses’ knowledge, attitudes, and practice in relation to pharmacovigilance and adverse drug reaction reporting: A systematic review,” Biomed Res. Int., vol. 2021, p. 6630404, 2021

Sharad AK. Pharmacists' knowledge, attitude and practice about adverse drug reaction in Basra/Iraq. Int J Pharm Sci Res. 2017 May 1;8(5):2309.

K. P. Osamene and M. Afolabi, “An evaluation of the knowledge and perceptions of pharmacy students on pharmacovigilance activities in Nigeria. BMC research notes,” vol. 10, pp. 1–9, 2017.

B. A. Adenuga, D. Kibuule, and T. W. Rennie, “Optimizing spontaneous adverse drug reaction reporting in public healthcare setting in Namibia,” Basic Clin. Pharmacol. Toxicol., vol. 126, no. 3, pp. 247–253, 2020.

T. R. Bagle, V. A. Vare, R. C. Hire, and A. O. Shukla, “Knowledge, attitude and practice of undergraduate medical students and interns towards pharmacovigilance,” Int. J. Basic Clin. Pharmacol., vol. 6, no. 8, p. 1904, 2017

S. K. Gupta, R. P. Nayak, R. Shivaranjani, and S. K. Vidyarthi, “A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India,” Perspect. Clin. Res., vol. 6, no. 1, pp. 45–52, 2015.

K. K. Knapp, H. Katzman, J. S. Hambright, and D. H. Albrant, “Community pharmacist interventions in a capitated pharmacy benefit contract,” Am. J. Health. Syst. Pharm., vol. 55, no. 11, pp. 1141–1145, 1998.

M. Bakare, A. I. Oreagba, and B. Adeniran, “Drug therapy problems: pharmacists’ interventions and outcomes in Lagos state general hospitals, South West, Nigeria West African Postgraduate College of Pharmacists (Nigerian Chapter),” Newsletter, vol. 1, no. 4, pp. 10–29, 2011

K. P. Osamene, M. I. Ayeni, and A. Mo, “The role of community pharmacists in monitoring adverse drug reactions in Nigeria,” Journal of Pharmaceutical Health Services Research, vol. 3, no. 4, pp. 197–204, 2012.

A.?;. S. Oparah, M. I. Ibrahim, and P. Mishra, “Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal. Pharmacy practice,” vol. 9, 2010.

E. O. Okezie and I. Fo, “Adverse drug reactions reporting by physicians in Ibadan, Nigeria,” Pharmacoepidemiology and drug safety, vol. 17, pp. 517–522, 2008.

E. Hristov et al., “Effect of pharmacist involvement on patient reporting of adverse drug reactions in Bulgaria,” Journal of Advanced Research in Pharmaceutical Sciences and Pharmacology Interventions, vol. 2, no. 2, pp. 1–6, 2019.

F. Vural, S. Çiftçi, and B. Vural, “The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital,” Northern clinics of Istanbul, vol. 1, no. 3, 2014.

A. Hammour and K. El-Dahiyat, Abu Farha R. Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in, vol. 23. Amman, Jordan, 2017.

F. Vural, S. Çiftçi, and B. Vural, “The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital,” Northern clinics of Istanbul, vol. 1, no. 3, 2014.

S. A. Khan, C. Goyal, N. Chandel, and M. Rafi, “Knowledge, attitudes, and practice of doctors to adverse drug reaction reporting in a teaching hospital in India: An observational study,” Journal of natural science, vol. 4, no. 1, 2013.

P. Gupta and A. Udupa, “Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions amongst resident doctors,” Journal of pharmaceutical sciences and research, vol. 3, no. 2, 2011.

J. K. Bajaj and K. Rakesh, “A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India,” Journal of clinical and diagnostic research: JCDR, vol. 7, no. 1, 2013.

R. Rajesh, S. Vidyasagar, and D. M. Varma, “An educational intervention to assess knowledge attitude practice of pharmacovigilance among health care professionals in an Indian tertiary care teaching hospital,” Int J Pharm Tech Res, vol. 3, no. 2, pp. 678–692, 2011.

S. A. Pimpalkhute, K. M. Jaiswal, S. D. Sontakke, C. S. Bajait, and A. Gaikwad, “Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring in resident doctors of a tertiary care teaching hospital,” Indian J. Med. Sci., vol. 66, no. 3–4, pp. 55–61, 2012.

P. Gupta, A. R. Anvikar, N. Valecha, and Y. K. Gupta, Pharmacovigilance practices for better healthcare delivery: knowledge and attitude study in the national malaria control programme of India. Malaria research and treatment. 2014.

R. Rajalakshmi, B. V. Devi, T. D. Prasad, S. Swetha, and B. Dharini, “Knowledge, attitude and practice towards pharmacovigilance and adverse drug reaction reporting among nurses in a tertiary care hospital, tirupati,” International Journal of Pharmaceutical and Clinical Research, vol. 9, no. 11, 2017.

L. Hazell and S. A. W. Shakir, “Under-reporting of adverse drug reactions: A systematic review,” Drug Saf., vol. 29, no. 5, pp. 385–396, 2006.

E. Lopez-Gonzalez, M. T. Herdeiro, and A. Figueiras, “Determinants of under-reporting of adverse drug reactions,” Drug safety, vol. 32, pp. 19–31, 2009.

C. Palleria et al., “Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two ‘challenging’ case reports,” Journal of Pharmacology and Pharmacotherapeutics, vol. 4, pp. S66-72, 2013.

J. O. Fadare, O. O. Enwere, A. O. Afolabi, B. A. Chedi, and A. Musa, “Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria,” Tropical Journal of Pharmaceutical Research, vol. 10, no. 3, 2011.

M. Bisht, S. Singh, and D. C. Dhasmana, “Effect of educational intervention on adverse drug reporting by physicians: A cross-sectional study,” ISRN Pharmacol., vol. 2014, pp. 1–8, 2014.

R. Gupta, D. Sharma, and P. Malhotra, “assessment of knowledge, attitude and practice of pharmacovigilance among the undergraduate medical students in a Northern Indian tertiary care teaching hospital-an observational study,” international journal of pharmaceutical sciences and research, vol. 8, pp. 2654–2659, 2017.

C. C. Smith et al., “Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines,” British journal of clinical pharmacology, vol. 42, no. 4, pp. 423–429, 1996.

M. B. Vora, N. P. Paliwal, V. G. Doshi, M. J. Barvaliya, and C. B. Tripathi, “Knowledge of adverse drug reactions and pharmacovigilance activity among the undergraduate medical students of Gujarat,” International Journal of Pharmaceutical Sciences and Research, vol. 3, no. 5, 2012.

S. Chatterjee, N. Lyle, and S. Ghosh, “A survey of the knowledge, attitude and practice of adverse drug reaction reporting by clinicians in eastern India,” Drug Safety, vol. 29, no. 7, pp. 641–642, 2006.

S. Kanwar, S. K. Mathur, and D. Yadav, “A questionnaire-based study on the knowledge, attitude and practice of pharmacovigilance among the medical officers working in peripheral areas of Ajmer District, Rajasthan (India),” Galore International Journal of Health Sciences and Research, vol. 5, no. 1, pp. 84–88, 2020.

K. Rajarathna, D. Sreedhar, D. Basavalingu, and C. R. Jayanthi, Eds., “416 A questionnaire study to assess the knowledge, attitude and practice of Pharmacovigilance in a paediatric tertiary care centre *Sushma Muraraiah,” J. Chem. Pharm. Res, vol. 3, no. 6, pp. 416–422, 2011.

Q. Li et al., “Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions,” Chinese medical journal, vol. 117, pp. 856–861, 2004.

R. K. Dikshit, C. Desai, and M. K. Desai, “Pleasures and pains of running a pharmacovigilance center,” Indian journal of pharmacology, vol. 40, 2008.

C. Biagi, N. Montanaro, E. Buccellato, G. Roberto, A. Vaccheri, and D. Motola, “Underreporting in pharmacovigilance: an intervention for Italian GPs (Emilia-Romagna region),” European journal of clinical pharmacology, vol. 69, no. 2, pp. 237–244, 2013.

M. Bäckström and T. Mjörndal, “A small economic inducement to stimulate increased reporting of adverse drug reactions-a way of dealing with an old problem,” European journal of clinical pharmacology, vol. 62, no. 5, pp. 381–385, 2006.

J. H. Lee, K. H. Park, H. J. Moon, Y. W. Lee, J. W. Park, and C. S. Hong, “Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea,” Yonsei medical journal, vol. 53, pp. 1022–1027, 2012.

K. Wilbur, “Pharmacovigilance in Qatar: a survey of pharmacists,” East Mediterr Health J, vol. 19, no. 11, pp. 930–935, 2013.

Gambia. UNESCO Institute of Statistics. UNESCO; 2017. Available from: http://uis.unesco.org/en/country/gm

S. Palaian, M. I. Ibrahim, and P. Mishra, “Health professionals’ knowledge, attitude and practices towards pharmacovigilance in Nepal,” Pharmacy practice, vol. 9, 2011.

H. S. Rehan, R. K. Sah, and D. Chopra, “Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital. Indian journal of pharmacology,” vol. 44, 2012.

C. K. Desai, G. Iyer, J. Panchal, S. Shah, and R. K. Dikshit, “An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital,” Perspectives in Clinical research, vol. 2, no. 4, 2011.

E. Hristov et al., “Effect of pharmacist involvement on patient reporting of adverse drug reactions in Bulgaria,” Journal of Advanced Research in Pharmaceutical Sciences and Pharmacology Interventions, vol. 2, no. 2, pp. 1–6, 2019.

S. Sivadasan and M. Sellappan, “A STUDY ON THE AWARENESS AND ATTITUDE TOWARDS PHARMACOVIGILANCE AND ADVERSE DRUG REACTION REPORTING AMONG NURSING STUDENTS IN A PRIVATE UNIVERSITY, MALAYSIA”,” International Journal of Current Pharmaceutical Research, vol. 7, no. 1, pp. 84–89, 2015

Downloads

Published

2022-12-02

How to Cite

Precious Ejiohuo. (2022). Knowledge, Attitudes, and Practices Towards Pharmacovigilance Amongst Healthcare Providers at Edward Francis Small Teaching Hospital in the Gambia. International Journal of Sciences: Basic and Applied Research (IJSBAR), 66(1), 102–135. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/14686

Issue

Section

Articles